Login / Signup

Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma.

Fernanda Sperb-LudwigTaciane AlegraRenata Voltolini VelhoNataniel LudwigMarina SiebertMariana JobimFilippo Pinto E VairoIda V D Schwartz
Published in: Genetics and molecular biology (2019)
Mucolipidosis II and III (ML II and III) alpha/beta and ML III gamma are lysosomal diseases caused by GlcNAc-1-phosphotransferase deficiency. Previous data indicate that MLII patients have functionally impaired immune system that contributes to predisposition to infections.We evaluated the immunological phenotype of three Brazilian patients with ML III gamma. Our data suggest that the residual activity of GlcNAc-1-phosphotransferase in patients with ML III gamma is enough to allow the targeting of the lysosomal enzymes required for B-cell functions maintenance.
Keyphrases
  • immune response
  • electronic health record
  • ejection fraction
  • end stage renal disease
  • dendritic cells
  • drug delivery
  • prognostic factors
  • data analysis